These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24372650)

  • 41. Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo.
    Song YC; Chou AH; Homhuan A; Huang MH; Chiang SK; Shen KY; Chuang PW; Leng CH; Tao MH; Chong P; Liu SJ
    J Leukoc Biol; 2011 Aug; 90(2):323-32. PubMed ID: 21521754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity.
    Ru Q; Shang BY; Miao QF; Li L; Wu SY; Gao RJ; Zhen YS
    Eur J Pharm Sci; 2012 Nov; 47(4):781-9. PubMed ID: 22982402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos.
    Gentry SB; Nowak SJ; Ni X; Hill SA; Wade LR; Clark WR; Keelaghan AP; Morris DP; McMurry JL
    PLoS One; 2021; 16(9):e0254468. PubMed ID: 34473728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The cellular pathway of CD1e in immature and maturing dendritic cells.
    Angénieux C; Fraisier V; Maître B; Racine V; van der Wel N; Fricker D; Proamer F; Sachse M; Cazenave JP; Peters P; Goud B; Hanau D; Sibarita JB; Salamero J; de la Salle H
    Traffic; 2005 Apr; 6(4):286-302. PubMed ID: 15752135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
    Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
    J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tat-functionalized near-infrared emissive polymersomes for dendritic cell labeling.
    Christian NA; Milone MC; Ranka SS; Li G; Frail PR; Davis KP; Bates FS; Therien MJ; Ghoroghchian PP; June CH; Hammer DA
    Bioconjug Chem; 2007; 18(1):31-40. PubMed ID: 17226955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses.
    Fanales-Belasio E; Moretti S; Nappi F; Barillari G; Micheletti F; Cafaro A; Ensoli B
    J Immunol; 2002 Jan; 168(1):197-206. PubMed ID: 11751963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
    Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E
    Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TAT peptide internalization: seeking the mechanism of entry.
    Vivès E; Richard JP; Rispal C; Lebleu B
    Curr Protein Pept Sci; 2003 Apr; 4(2):125-32. PubMed ID: 12678851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
    Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
    J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells.
    Niu X; Gao Z; Qi S; Su L; Yang N; Luan X; Li J; Zhang Q; An Y; Zhang S
    Int J Nanomedicine; 2018; 13():4895-4911. PubMed ID: 30214196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.
    Richard JP; Melikov K; Brooks H; Prevot P; Lebleu B; Chernomordik LV
    J Biol Chem; 2005 Apr; 280(15):15300-6. PubMed ID: 15687490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins.
    Caron NJ; Quenneville SP; Tremblay JP
    Biochem Biophys Res Commun; 2004 Jun; 319(1):12-20. PubMed ID: 15158435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
    van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
    PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
    Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
    Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective Intracellular Delivery of Ganglioside GM3-Binding Peptide through Caveolae/Raft-Mediated Endocytosis.
    Matsubara T; Otani R; Yamashita M; Maeno H; Nodono H; Sato T
    Biomacromolecules; 2017 Feb; 18(2):355-362. PubMed ID: 28051846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins.
    Shen Y; Nagpal P; Hay JG; Sauthoff H
    J Control Release; 2014 Aug; 188():44-52. PubMed ID: 24928321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic applications of the cell-penetrating HIV-1 Tat peptide.
    Rizzuti M; Nizzardo M; Zanetta C; Ramirez A; Corti S
    Drug Discov Today; 2015 Jan; 20(1):76-85. PubMed ID: 25277319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.